Todd E. Fox

4.1k total citations
83 papers, 3.1k citations indexed

About

Todd E. Fox is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Todd E. Fox has authored 83 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 24 papers in Immunology and 18 papers in Cell Biology. Recurrent topics in Todd E. Fox's work include Sphingolipid Metabolism and Signaling (55 papers), Lipid Membrane Structure and Behavior (24 papers) and Protein Kinase Regulation and GTPase Signaling (9 papers). Todd E. Fox is often cited by papers focused on Sphingolipid Metabolism and Signaling (55 papers), Lipid Membrane Structure and Behavior (24 papers) and Protein Kinase Regulation and GTPase Signaling (9 papers). Todd E. Fox collaborates with scholars based in United States, Spain and Egypt. Todd E. Fox's co-authors include Mark Kester, Thomas P. Loughran, Jong K. Yun, Lindsay Ryland, Xin Liu, Hong‐Gang Wang, Myles C. Cabot, Gavin P. Robertson, Yasser Heakal and Brian M. Barth and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Genes & Development.

In The Last Decade

Todd E. Fox

81 papers receiving 3.1k citations

Peers

Todd E. Fox
Jong K. Yun United States
Xin A. Zhang United States
Dante Neculai China
Melanie A. Simpson United States
Patric Turowski United Kingdom
Yasuo Kubota Japan
Margit Rosner Austria
Toshifumi Azuma Japan
Henrique Girão Portugal
Jong K. Yun United States
Todd E. Fox
Citations per year, relative to Todd E. Fox Todd E. Fox (= 1×) peers Jong K. Yun

Countries citing papers authored by Todd E. Fox

Since Specialization
Citations

This map shows the geographic impact of Todd E. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd E. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd E. Fox more than expected).

Fields of papers citing papers by Todd E. Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd E. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd E. Fox. The network helps show where Todd E. Fox may publish in the future.

Co-authorship network of co-authors of Todd E. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Todd E. Fox. A scholar is included among the top collaborators of Todd E. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd E. Fox. Todd E. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pal, Ipsita, Anuradha Illendula, John S. Manavalan, et al.. (2025). Nanoromidepsin, a polymer nanoparticle of the HDAC inhibitor, improves safety and efficacy in models of T-cell lymphoma. Blood. 146(23). 2794–2807.
2.
Gourdin, Theodore Stewart, et al.. (2023). A phase I study of the ceramide nanoliposome in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 93(1). 23–29. 8 indexed citations
3.
Fisher‐Wellman, Kelsey H., Miki Kassai, P. Darrell Neufer, et al.. (2023). Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia. Cancers. 15(6). 1883–1883. 5 indexed citations
4.
O’Connor, Owen A., Anuradha Illendula, Kallesh D. Jayappa, et al.. (2023). Synthesis and Preclinical Development of a Promising Novel Romidepsin Nanoparticle for the Treatment of Peripheral T‐Cell Lymphoma (PTCL). Hematological Oncology. 41(S2). 548–548. 1 indexed citations
5.
Qi, Xiaoqiang, Feng Wu, Sung Hoon Kim, et al.. (2022). Nanoliposome C6‐Ceramide in combination with anti‐CTLA4 antibody improves anti‐tumor immunity in hepatocellular cancer. The FASEB Journal. 36(4). e22250–e22250. 13 indexed citations
6.
Tan, Su‐Fern, Todd E. Fox, Jeremy J.P. Shaw, et al.. (2022). Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia. Blood Reviews. 55. 100950–100950. 12 indexed citations
7.
8.
Raymond, Michael H., Kasey Jividen, Jeremy J.P. Shaw, et al.. (2020). Role of SPTSSB-Regulated de Novo Sphingolipid Synthesis in Prostate Cancer Depends on Androgen Receptor Signaling. iScience. 23(12). 101855–101855. 6 indexed citations
9.
Shaw, Jeremy J.P., et al.. (2020). Inhibition of Lysosomal Function Mitigates Protective Mitophagy and Augments Ceramide Nanoliposome–Induced Cell Death in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 19(12). 2621–2633. 14 indexed citations
10.
Pearson, Jennifer M., Su‐Fern Tan, Arati Sharma, et al.. (2019). Ceramide Analogue SACLAC Modulates Sphingolipid Levels and MCL-1 Splicing to Induce Apoptosis in Acute Myeloid Leukemia. Molecular Cancer Research. 18(3). 352–363. 23 indexed citations
11.
Shaw, Jeremy J.P., et al.. (2019). Glucosylceramidase Maintains Influenza Virus Infection by Regulating Endocytosis. Journal of Virology. 93(12). 37 indexed citations
12.
Moore, John H., Walter Varhue, Todd E. Fox, et al.. (2019). Conductance-Based Biophysical Distinction and Microfluidic Enrichment of Nanovesicles Derived from Pancreatic Tumor Cells of Varying Invasiveness. Analytical Chemistry. 91(16). 10424–10431. 35 indexed citations
13.
Li, Guangfu, Dai Liu, Eric T. Kimchi, et al.. (2018). Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice. Gastroenterology. 154(4). 1024–1036.e9. 123 indexed citations
14.
15.
Zhang, Xuewei, Kazuyuki Kitatani, Masafumi Toyoshima, et al.. (2017). Ceramide Nanoliposomes as a MLKL-Dependent, Necroptosis-Inducing, Chemotherapeutic Reagent in Ovarian Cancer. Molecular Cancer Therapeutics. 17(1). 50–59. 45 indexed citations
16.
LeBlanc, Francis, Xin Liu, Jeremy A. Hengst, et al.. (2015). Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia. Cancer Biology & Therapy. 16(12). 1830–1840. 23 indexed citations
17.
Madhunapantula, SubbaRao V., Jeremy A. Hengst, Raghavendra Gowda, et al.. (2012). Targeting sphingosine kinase‐1 to inhibit melanoma. Pigment Cell & Melanoma Research. 25(2). 259–274. 44 indexed citations
18.
Fox, Todd E., Maria C. Bewley, Robert E. Anderson, et al.. (2010). Circulating sphingolipid biomarkers in models of type 1 diabetes. Journal of Lipid Research. 52(3). 509–517. 122 indexed citations
19.
Salli, Ugur, Todd E. Fox, Nurgul Carkaci‐Salli, et al.. (2008). Propagation of Undifferentiated Human Embryonic Stem Cells with Nano-Liposomal Ceramide. Stem Cells and Development. 18(1). 55–66. 16 indexed citations
20.
Fox, Todd E., Sean O’Neill, Murali Nagarajan, et al.. (2007). Ceramide Recruits and Activates Protein Kinase C ζ (PKCζ) within Structured Membrane Microdomains. Journal of Biological Chemistry. 282(17). 12450–12457. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jong K. Yun Breakdown of academic impact, for papers by Xin A. Zhang Breakdown of academic impact, for papers by Dante Neculai Breakdown of academic impact, for papers by Melanie A. Simpson Breakdown of academic impact, for papers by Patric Turowski Breakdown of academic impact, for papers by Yasuo Kubota Breakdown of academic impact, for papers by Margit Rosner Breakdown of academic impact, for papers by Toshifumi Azuma Breakdown of academic impact, for papers by Henrique Girão
Rankless by CCL
2026